logo

Delivering personalized medicine one patient at a time

About

Hunter Laboratories is dedicated to delivering excellence in laboratory medicine, one patient at a time. While laboratory tests account for only 2% of medical costs, approximately 80% of medical decisions are driven by laboratory test information. The right medical tests can dramatically reduce the costs of therapy by defining what therapies and drugs work best. Hunter offers a comprehensive array of laboratory tests, including advanced new tests and treatment algorithms to assist physicians in diagnosis and treatment. Through its development partnerships with in-vitro diagnostics manufacturers and life science companies, Hunter is committed to maintaining its reputation for innovation and service.
Chris Riedel
C.E.O.
Mr. Riedel is a visionary, who prior to Hunter Labs, was the founder and C.E.O. of three Health Care Companies, which achieved the following: 1974-Micremedia Systems, developed assay panels for hospitals and independent clinical labs; 1978-Microscan, pioneered antibiotic susceptibility testing and bacterial identification, this system is now the worldwide industry leader; 1985-Meris Laboratory, established "breakthrough" service levels, by 1992 Meris became the third largest laboratory in California. He then proceeded to take the company through an IPO and SPO raising over $53 million. In May of 1992, Meris was ranked by Business Week as the 40th best small company in America. Mr. Riedel, in addition to being an avid community supporter, has spent many years volunteering as a coach for soccer and basketball. He earned a BA degree from the University of California at Berkeley. Mr. Riedel also has served as a member of the Board of Directors of the Boston Heart Lab.
Marcia Riedel
President
Ms. Riedel has over 20 years of clinical laboratory experience. She developed her technical and operational skill set at Massachusetts General Hospital. At Meris Laboratories, under her leadership as V.P. of Sales & Marketing, she lead internal growth of 37% per year, successfully integrated 14 acquisitions with customer retention exceeding 90% in a highly fragmented and competitive market. Mrs. Riedel has dedicated over fifteen years of philanthropic work in Junior League and various non-profit activities. She received the "Woman Making a Mark" recognition award from San Jose Magazine and the California Legislature for her active community role in 2005. Mrs. Riedel earned a double degree in Management and English at the University of Massachusetts. She has also completed executive course work at Harvard Business School.
Gerald Weiss
Medical Director, M.D., F.C.A.P.
Dr. Weiss received his M.D. with Distinction from the University of Alberta, Canada, and completed residency in Anatomic and Clinical Pathology at Santa Clara Valley Medical Center. Dr. Weiss has served as the Laboratory Director for San Jose Medical Center and for Regional Medical Center of San Jose. He is past President of the medical staff at San Jose Medical Center. Since 1995 Dr. Weiss has served as a member of the California Society of Pathologists Board of Directors, and since 2000 as the Pathology representative for the N. CA Medicare Clinical Advisory Committee. He is board certified in Clinical and Anatomic Pathology.
Richard H. Prendergast
Vice President Sales & Marketing
Mr. Prendergast has had extensive experience in the clinical laboratory industry. His experience includes managing sales, patient service centers, couriers and customer service. Prior to Hunter Labs, Mr. Prendergast was V.P.of Sales and Marketing for Immuno Diagnostic Lab. He was also New Business Manager for LabCorp Northern California where he led sales and participated in building $29 million in annual revenue. His passion for sports and children made him a very successful coach as he volunteered his time to youth and teen soccer. Mr. Prendergast attended the University of Tampa, majoring in Business where he was a member of their Divisional II finalist team.
Michael McNulty
Chief Operating Officer
Mr. McNulty joined Hunter Laboratories in 2011 as Chief Operating Officer. From 2004 through 2010 Mr. McNulty served as the General Manager, Molecular Diagnostics at Agilent Technologies. While at Agilent, Mr. McNulty directed initiatives to bring microarray, microfluidic and mass spectrometry applications to clinical laboratories. Prior to Agilent, Michael was Vice President of Operations and Chief Compliance Officer at Berkeley HeartLabs, a CLIA laboratory focused on cardiovascular risk assessment. Mr. McNulty has also held management positions as Vice President SBCL/Quest Diagnostic (17-years), Vice President Sales and Marketing ThauMDx (3-years) and Product Manager, SYVA/Dade (5-years). Michael is trained in clinical chemistry, microbiology, clinical toxicology, and is certified in regulatory affairs. Mr. McNulty currently serves on the Board of Directors of Transgenomics and the Scientific Advisory Board of NuGen, Inc.
Rose Romeo
Ph.D., D.A.B.C.C., F.A.C.B. - Laboratory Director
Rose Romeo is a board certified clinical chemist who has worked in both the medical device and clinical laboratory industries for over 20 years. Her areas of expertise include strategic and logistical laboratory operations, clinical trial planning and implementation, quality systems implementation and regulatory submissions. Past positions have included UCSF/San Francisco General Hospital, SurroMed, Agilent Technologies, XDx and Roche Molecular Systems.
Rose received her graduate degree in pathology & molecular biology from Albany Medical College (Albany, NY) and is a board certified by the American Board of Clinical Chemistry and the National Registry of Clinical Chemistry. She is also licensed as a clinical chemist by the State of California. She is an active member of the American Association for Clinical Chemistry and the National Academy of Clinical Biochemists and is also a member of the Regulatory Affairs Professional Society.
S. Robert Freedman
M.D., F.C.A.P. - Associate Pathologist
Dr. Friedman received his M.D. from Jefferson Medical College. He completed an internship in Internal Medicine at the University of Illinois, and a residency in Anatomic Pathology, Laboratory Medicine and Nuclear Medicine at Mt. Zion Hospital and Medical Center. Dr. Freedman has served as the Laboratory Director at both Regional Medical Center in San Jose and Community Hospital in Los Gatos. Since 1998 Dr. Freedman has served as a member of the California Society of Pathologists Board of Directors and is past president of the board. He has also served as President of the South Bay Pathology Society, V.P. for Professional Conduct of the Santa Clara County Medical Association, CMA House of Delegates, Clinical Laboratory Technical Advisory Committee (CLTAC) for the State of California, and is an Inspector for Laboratory Accreditation for the College of American Pathologists Accreditation Program. He is board certified in Clinical and Anatomic Pathology.
Sudha Rao
M.D., F.C.A.P. - Associate Pathologist
Dr. Rao received her M.D. from Bangalore Medical College in Bangalore, India. She completed residency in Anatomic and Clinical Pathology at the University Massachusetts Medical Center, where she was the Chief Resident. She also completed a Surgical Pathology Fellowship at the Mayo Clinic. Since 2001 Dr. Rao has served as the Vice Chair of the Pathology Department at Los Gatos Community Hospital. She is board certified in Clinical and Anatomic Pathology.
Jyothsna Narla
M.D., F.C.A.P. - Blood Bank Specialist, Associate Pathologist
Dr. Narla received her M.D. from Andhra University, Waltair, India. She completed residency in Anatomic Pathology at William Beaumont Hospital in Royal Oak, MI., and in Laboratory Medicine and Clinical Pathology at UCSF. Dr. Narla served as the Assistant Medical Director for the Irwin Memorial Blood Bank in San Francisco for five years and has practiced pathology at Seton Medical Center in Daly City, Los Gatos Community Hospital and Regional Medical Center of San Jose where she is the Vice Chairman of the Department of Pathology. She is a Diplomat for the American Board of Anatomic Pathology and the American Board of Clinical Pathology. Dr. Narla is board certified in Clinical and Anatomic Pathology and has a Specialty Board in Blood Banking.
Edward Ellsworth
M.D., F.C.A.P. - Associate Pathologist
Dr. Ellsworth received his M.D. from the University of Wisconsin School of Medicine and completed residency in Pathology at Cedars-Sinai Medical Center. He has served as Chairman for the Department of Pathology at San Jose Medical Center and currently practices Pathology at Regional Medical Center of San Jose, where he has served as a member of the Board of Trustees. Dr. Ellsworth is a Diplomate for the American Board of Anatomic Pathology and the American Board of Clinical Pathology, and is a Fellow in the College of American Pathologists. He is board certified in Clinical and Anatomic Pathology.